Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7022882
NMDA receptor channel blocker with neuroprotective activity
expired patentUS 7022834
Isotopically labelled DNA
expired patentUS 7005129
Non-toxic mutants of pathogenic gram-negative bacteria
expired patentUS 7005411
Method for modulating nerve cell function
expired patentUS 7005274
Methods and compositions for diagnosing and treating arthritic disorders and regulating bo
expired patentUS 7005269
ERAAP modulators regulate immune responses
expired patentUS 7002002
Abundant extracellular products and methods for their production and use
expired patentUS 6998513
Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and metho
expired patentUS 6991794
Progenitor cell preservation factors and methods for and products of their use
expired patentUS 6989146
Stress proteins and peptides and methods of use thereof
expired patentUS 6987193
Illudin analogs useful as antitumor agents
expired patentUS 6984622
Use of lipopolysaccharides to manage corneal infections and wounds
expired patentUS 6982361
Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout ani
expired patentUS 6979730
Nucleic acids encoding prostate stem cell antigen
expired patentUS 6974568
Treatment for cough
expired patentUS 6974580
Mycobacterial sulfation pathway proteins and methods of use thereof
expired patentUS 6967019
Production of pancreatic islet cells and delivery of insulin
expired patentUS 6967240
Congener independent detection of microcystin and nodularin congeners
expired patentUS 6967093
Glycosyl sulfotransferase-3
expired patentUS 6960443
Methods of detecting prostate stem cell antigen in cancer
expired patentUS 6958238
Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods
expired patentUS 6956145
Mice models of human prostate cancer progression
expired patentUS 6955894
Method for producing TNF receptor releasing enzyme
expired patentUS 6953575
Methods of treating central nervous system disorders using viral vectors
expired